Detalhe da pesquisa
1.
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial.
Blood
; 135(24): 2137-2145, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32219442
2.
Can Less Intensive Chemotherapy and an Autotransplant Cure Adult T-Cell Acute Lymphoblastic Leukemia?
Acta Haematol
; 143(2): 131-139, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31597157
3.
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 20(1): 43-56, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522969
4.
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial.
Pharm Res
; 36(7): 93, 2019 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31044267
5.
Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
N Engl J Med
; 372(10): 944-53, 2015 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25738670
6.
Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma.
Am J Hematol
; 2018 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29726031
7.
Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.
Blood
; 126(16): 1893-901, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26232170
8.
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
Lancet Oncol
; 17(2): 200-211, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26655421
9.
Corrosion Resistance of Al0.5CoCrFeNiCuxAgy (x = 0.25, 0.5; y = 0, 0.1) High-Entropy Alloys in 0.5M H2SO4 Solution.
Materials (Basel)
; 16(9)2023 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37176467
10.
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
Leukemia
; 37(7): 1464-1473, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37202442
11.
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study.
Lancet Haematol
; 10(11): e902-e912, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914483
12.
Al0.25CoCrFeNiV High Entropy Alloy Coating Deposited by Laser Cladding on Stainless Steel.
Materials (Basel)
; 15(20)2022 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36295120
13.
Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.
EJHaem
; 3(4): 1241-1251, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36467842
14.
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study.
Clin Lymphoma Myeloma Leuk
; 22(2): 89-97, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34686445
15.
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.
N Engl J Med
; 359(9): 906-17, 2008 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-18753647
16.
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.
Eur J Haematol
; 86(5): 372-84, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21366694
17.
High-Temperature Oxidation of High-Entropic Alloys: A Review.
Materials (Basel)
; 14(10)2021 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34065772
18.
Properties of WC-10%Co-4%Cr Detonation Spray Coating Deposited on the Al-4%Cu-1%Mg Alloy.
Materials (Basel)
; 14(5)2021 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33806596
19.
A Study of Characteristics of Aluminum Bronze Coatings Applied to Steel Using Additive Technologies.
Materials (Basel)
; 13(2)2020 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31963647
20.
Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Leuk Lymphoma
; 61(13): 3188-3197, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762271